UDCAK9 contains Ursodeoxycholic Acid that belongs to the group of medicines called Hepatoprotective agents. It is used to dissolve gallstones in various liver-related disorders such as cirrhosis, sclerosing cholangitis, and liver dysfunction.
Features:
- UDCA slows PBC progression, decrease liver transplant need.
- UDCA is an alternative to cholecystectomy for gallbladder stones treatment.
- Improves bile acid composition and viscosity.
- Reduces gall bladder stones and their occurrence.
- Reduces inflammation and cell damage.
Each Film Coated Tablet Contains:
- Ursodeoxycholic Acid IP 150 mg / 300 mg
Uses:
UDCAK9 may use in the treatment of inflammatory hepatobiliary diseases:
- Primary Biliary Cirrhosis (PBC)
- Prevention of Gallstone formation
- Cholestatic Liver Disease
- Hepatoprotection
Dosage:
- As directed by the Veterinarian.
Presentation:
- UDCAK9-150 / 300 is available as 1X15 Tablets in a strip.
- For use in Dogs and Cats.
Our Other Products
K9PEA
Palmitoylethanolamide (PEA) 300 mg, Daidzein 50 mg and Genistein 4 mg Tablets
LAFK9
Lactoferrin 100 mg and Disodium Guanosine 5-Monophosphate 10 mg Tablets
TUMK9
90 Billion CFU Probiotic Capsules
BOULK9
Saccharomyces Boulardii CNCM I-1079 capsules 250 mg (5 Billion CFU)
XIMSIBO – 200/400
Rifaximin Tablets IP 200 mg / 400 mg
SOBIRENK9 – 500
Sodium Bicarbonate Tablets IP 500 mg
PHORALK9-400/800
Sevelamer Tablets 400 mg / 800 mg